Nitric Oxide & Circulation

Nitric Oxide: The Vascular Signalling Molecule

Nitric oxide (NO) — synthesised from L-arginine by nitric oxide synthase enzymes — is the primary endogenous vasodilator and a critical regulator of vascular tone, platelet function, and endothelial health. Three NOS isoforms exist: neuronal (nNOS), inducible (iNOS), and endothelial (eNOS). Endothelial eNOS is the primary source of vascular NO in healthy physiology. NO produced by eNOS diffuses to adjacent vascular smooth muscle cells, activates soluble guanylyl cyclase (sGC), generates cGMP, and produces smooth muscle relaxation — vasodilation. Endothelial dysfunction — the loss of adequate eNOS-derived NO production — is the earliest detectable stage of cardiovascular disease and precedes atherosclerotic plaque formation by years to decades. Restoring eNOS activity and NO bioavailability is therefore a central therapeutic target in cardiovascular medicine.

Epicatechin: The eNOS Activator

Epicatechin — cacao's primary bioactive flavanol — activates eNOS through a precisely characterised intracellular signalling cascade. Epicatechin binds endothelial cell surface receptors and activates phosphoinositide 3-kinase (PI3K), which phosphorylates Akt (protein kinase B) at Thr308 and Ser473. Activated Akt phosphorylates eNOS at Ser1177 — its primary activating phosphorylation site — converting eNOS from a calcium-dependent to a calcium-independent, constitutively active state. This produces sustained NO generation independent of the calcium flux that normally gates eNOS activity. The result is increased baseline NO production in endothelial cells — elevating the resting vasodilatory tone of blood vessels and reducing peripheral vascular resistance.

NADPH Oxidase Inhibition: Protecting NO

Increased NO synthesis alone is insufficient if oxidative stress simultaneously destroys the NO produced. Superoxide (O₂•⁻) — generated primarily by NADPH oxidase in endothelial and inflammatory cells — reacts with NO at near-diffusion-limited rates to form peroxynitrite (ONOO⁻), which is both cytotoxic and incapable of vasodilation. Cacao epicatechin directly inhibits NADPH oxidase enzyme activity, reducing the primary endothelial ROS source. This dual action — simultaneously increasing NO synthesis (via eNOS) and reducing NO destruction (via NADPH oxidase inhibition) — produces a multiplicative increase in net NO bioavailability that explains why flavanol-rich cacao has stronger vascular effects than equivalent antioxidant capacity from non-flavanol sources.

Flow-Mediated Dilation: The Clinical Measure

Flow-mediated dilation (FMD) of the brachial artery — measured by ultrasound after brief arterial occlusion — is the standard non-invasive clinical measure of endothelial eNOS function. Higher FMD indicates better NO-mediated vasodilation capacity and lower cardiovascular risk. Multiple RCTs demonstrate that flavanol-rich cacao consumption significantly improves FMD: a meta-analysis of 11 trials found mean FMD improvement of 1.34% following high-flavanol cocoa — an effect comparable to pharmaceutical interventions targeting endothelial dysfunction. Critically, the FMD improvement is dose-dependent and occurs within hours of a single flavanol-rich cacao serving, with sustained improvement after weeks of regular consumption.

Clinical Measure	Effect	Reference
Flow-mediated dilation (FMD)	+1.34% mean improvement	Meta-analysis, 11 RCTs
Systolic blood pressure	−2–5 mmHg	42 RCTs (Hooper 2012)
Plasma nitrite/nitrate (NO markers)	Significantly elevated post-consumption	Multiple acute RCTs
Peripheral vascular resistance	Reduced	Consistent with FMD + BP data
Coronary vasomotion	Improved (Flammer et al.)	Circulation, 2007

Theobromine: Parallel Vasodilation

While epicatechin operates through eNOS, theobromine produces vasodilation through phosphodiesterase (PDE) inhibition — directly elevating intracellular cGMP in vascular smooth muscle without requiring NO as an intermediary. This PDE-inhibitor mechanism is the same pathway used by sildenafil (Viagra) and related vascular medications, though theobromine's PDE selectivity and potency are substantially lower — producing gentle, sustained vasodilation rather than acute pharmacological effects. The co-presence of epicatechin (eNOS → NO → cGMP) and theobromine (PDE inhibition → cGMP elevation) in ceremonial cacao means both upstream and downstream components of the vasodilatory cGMP pathway are engaged simultaneously — an unusual dietary combination.

Considerations

Vasodilatory effects of ceremonial cacao are beneficial for most adults but should be considered in the context of existing antihypertensive medications — additive blood pressure lowering effects may require monitoring. Individuals with severe hypotension should be aware of theobromine's vasodilatory contribution. The vascular effects of cacao are processing-dependent: alkalised Dutch-process cocoa retains insufficient flavanols to produce meaningful eNOS activation. This content is informational and does not constitute medical advice.